Skip to Main Content

Paper Details

Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options.
Pharmacol Ther
49
2022
TNBC, Triple negative breast cancer, Triple-negative breast cancer, Tumor, epigenome, patient, patients, transcriptome, tumor
Author NameAffiliation
Joyce E OhmRoswell Park Cancer Institute
Stanley LipkowitzCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Stanley LipkowitzCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 3

Datasets

Release 1.2